ATE245447T1 - Inhibitor von gehirnödemen - Google Patents

Inhibitor von gehirnödemen

Info

Publication number
ATE245447T1
ATE245447T1 AT96919984T AT96919984T ATE245447T1 AT E245447 T1 ATE245447 T1 AT E245447T1 AT 96919984 T AT96919984 T AT 96919984T AT 96919984 T AT96919984 T AT 96919984T AT E245447 T1 ATE245447 T1 AT E245447T1
Authority
AT
Austria
Prior art keywords
endothelin antagonist
treating
brain edemas
edemas
preventing
Prior art date
Application number
AT96919984T
Other languages
English (en)
Inventor
Mitsuyoshi Ninomiya
Yoshiyuki Matsuo
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE245447T1 publication Critical patent/ATE245447T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT96919984T 1995-06-02 1996-05-29 Inhibitor von gehirnödemen ATE245447T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16006095 1995-06-02
PCT/JP1996/001438 WO1996038173A1 (en) 1995-06-02 1996-05-29 Brain edema inhibitor

Publications (1)

Publication Number Publication Date
ATE245447T1 true ATE245447T1 (de) 2003-08-15

Family

ID=15707042

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96919984T ATE245447T1 (de) 1995-06-02 1996-05-29 Inhibitor von gehirnödemen

Country Status (16)

Country Link
US (1) US5945448A (de)
EP (1) EP0838223B1 (de)
JP (1) JP4011114B2 (de)
KR (1) KR100399797B1 (de)
CN (1) CN1083261C (de)
AT (1) ATE245447T1 (de)
AU (1) AU700182B2 (de)
BR (1) BR9608413A (de)
CA (1) CA2218028C (de)
DE (1) DE69629195T2 (de)
DK (1) DK0838223T3 (de)
ES (1) ES2202449T3 (de)
PT (1) PT838223E (de)
TR (1) TR199701497T1 (de)
TW (1) TW460286B (de)
WO (1) WO1996038173A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482857B1 (en) 1998-07-17 2002-11-19 The University Of Texas Southwestern Medical Center Compositions which contain triterpenes for regulating hair growth
US6124362A (en) * 1998-07-17 2000-09-26 The Procter & Gamble Company Method for regulating hair growth
TWI232102B (en) * 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
JP2007217438A (ja) * 2001-07-17 2007-08-30 Shionogi & Co Ltd 注射用医薬製剤
JP2006506445A (ja) 2002-08-28 2006-02-23 ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド 治療処置の方法
US7861479B2 (en) 2005-01-14 2011-01-04 Airlite Plastics, Co. Insulated foam panel forms
AU2007225139A1 (en) * 2006-03-13 2007-09-20 Encysive Pharmaceuticals, Inc. Methods and compositions for treatment of diastolic heart failure
US8080549B2 (en) 2007-01-12 2011-12-20 Concert Pharmaceuticals, Inc. Endothelin receptor antagonists
US8071596B2 (en) 2007-01-12 2011-12-06 Concert Pharmaceuticals, Inc. Endothelin receptor antagonists
US8919067B2 (en) 2011-10-31 2014-12-30 Airlite Plastics Co. Apparatus and method for construction of structures utilizing insulated concrete forms
US8887465B2 (en) 2012-01-13 2014-11-18 Airlite Plastics Co. Apparatus and method for construction of structures utilizing insulated concrete forms
USD713975S1 (en) 2012-07-30 2014-09-23 Airlite Plastics Co. Insulative insert for insulated concrete form
US10787827B2 (en) 2016-11-14 2020-09-29 Airlite Plastics Co. Concrete form with removable sidewall
CA3061942A1 (en) 2018-11-19 2020-05-19 Bradley J. Crosby Concrete form with removable sidewall

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0526642T3 (da) * 1991-01-29 1998-10-19 Shionogi & Co Triterpenderivat
ES2116663T3 (es) * 1993-06-11 1998-07-16 Shionogi & Co Compuestos intermediarios para la preparacion de derivados triterpenos antagonistas del receptor de endotelina.
US5599811A (en) * 1995-02-21 1997-02-04 Warner-Lambert Company Benzothiazine dioxides as endothelin antagonists

Also Published As

Publication number Publication date
DE69629195D1 (de) 2003-08-28
BR9608413A (pt) 1998-12-29
CA2218028C (en) 2010-07-06
JP4011114B2 (ja) 2007-11-21
DE69629195T2 (de) 2004-05-06
EP0838223A4 (de) 2001-04-25
AU700182B2 (en) 1998-12-24
KR100399797B1 (ko) 2004-04-13
EP0838223B1 (de) 2003-07-23
ES2202449T3 (es) 2004-04-01
CN1186441A (zh) 1998-07-01
EP0838223A1 (de) 1998-04-29
AU5844096A (en) 1996-12-18
US5945448A (en) 1999-08-31
KR19990008341A (ko) 1999-01-25
TW460286B (en) 2001-10-21
PT838223E (pt) 2003-12-31
DK0838223T3 (da) 2003-11-17
CA2218028A1 (en) 1996-12-05
WO1996038173A1 (en) 1996-12-05
TR199701497T1 (xx) 1998-06-22
MX9708920A (es) 1998-03-31
CN1083261C (zh) 2002-04-24

Similar Documents

Publication Publication Date Title
ATE195117T1 (de) 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren
DK0778834T3 (da) Bicykliske, heterocykliske diarylforbindelser som inhibitorer af cyclooxygenase-2
DE69629195D1 (de) Inhibitor von gehirnödemen
RU94036772A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования эндометриоза
DK0715623T3 (da) Blodpladeaggregationsinhibitorer
ATE147981T1 (de) Verabreichung von lamotrigin zur behandlung von neuro-aids
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
RU94044454A (ru) Ингибитор аутоимунных заболеваний
PT752813E (pt) Inibidores de proteases de parasitas metazoarios
WO1992019211A3 (en) Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
RU94044356A (ru) Применение 2-фенил-3-ароилбензотиофенов для увеличения экспрессии тромбомодулина для ингибирования тромботического расстройства, для увеличения активации протеина с
NO923199L (no) Terapeutiske forbindelser
DE60225143D1 (de) Synergistische pharmazeutische zusammensetzungen zur behandlung bzw. prophylaxe von diabetes
BR9506552A (pt) Método de inibição de integrase retroviral
DE69315699D1 (de) Inhibitoren gegen die aggregation von blutplättchen
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
DK0804418T3 (da) Platelataggregationshæmmere
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
ATE160143T1 (de) 2-substituierte morpholin- und thiomorpholinderivate als gaba-b antagonisten
ES2191763T3 (es) Inhibidor del desarrollo de dependencia/tolerancia a un agente analgesico narcotico.
KR950032194A (ko) 신규푸린유도체 및 그 약학적으로 허용되는 염
DK0720598T3 (da) Phenoxyphenylcyclopentenyl-hydroxyurinstoffer
ES2094638T3 (es) N-acilpirrolidinas y medicamentos para el tratamiento o la prevencion de los desordenes relacionados con la colecistoquinina y la gastrina.
DK0532177T3 (da) Methanoanthracener som dopaminantagonister
AR015458A1 (es) Compuestos de tetrahidrofurano, y composicion farmaceutica que lo contiene.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0838223

Country of ref document: EP

REN Ceased due to non-payment of the annual fee